Francois Nader Insider Trading
Get free email notifications about insider trading for Francois Nader.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Francois Nader. Francois Nader is a Chief Medical & Commercial Off in NPS PHARMACEUTICALS INC ($NPSP) and a Chief Operating Officer in NPS PHARMACEUTICALS INC ($NPSP) and a President, CEO and Director in NPS PHARMACEUTICALS INC ($NPSP) and a Director in ALEXION PHARMACEUTICALS INC ($ALXN) and a Director in ACCELERON PHARMA INC ($XLRN) and a Director in TREVENA INC ($TRVN) and a Director in Baxalta Inc ($BXLT) and a Director in Moderna, Inc. ($MRNA) and a Director in Prevail Therapeutics Inc. ($PRVL).
Address: 383 COLOROW DRIVE SALT LAKE CITY 84108 UT
Companies in which Francois Nader is an Insider
ACCELERON PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Francois Nader: Director
Holdings: 5,127 shares
Current Value: $121,715
Latest Transaction: Jan 24 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Francois Nader: Director
Holdings: 10,345 shares
Current Value: $1,321,263
Latest Transaction: May 18 2020
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Baxalta Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Francois Nader: Director
Holdings: 0 shares
Latest Transaction: Jun 07 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Moderna, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Francois Nader: Director
Holdings: 0 shares
Latest Transaction: Apr 30 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NPS PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Francois Nader: President, CEO and Director, Chief Operating Officer, Chief Medical & Commercial Off
Holdings: 0 shares
Latest Transaction: Feb 24 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prevail Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Francois Nader: Director
Holdings: 0 shares
Latest Transaction: Jan 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TREVENA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Francois Nader: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 21 2015
$TRVN Market Capitalization: $406.64M
$TRVN Previous Close: $7.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Francois Nader
Sentiment: All, XLRN, ALXN, BXLT, MRNA, NPSP, PRVL, TRVN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 0.00 | 703 | 0 | 703 | |
| Apr 30 2021 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 178.68 | 4,081 | 729,193 | 4,081 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | D | 10.26 | 32,000 | 328,320 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | D | 2.81 | 133,447 | 374,986 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Sell | U | 0.00 | 23,747 | 0 | 0 | 23.7 K to 0 (-100.00 %) |
| Jun 19 2020 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | A | 16.98 | 17,000 | 288,660 | 17,000 |